Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Chronic Rhinosinusitis: later-stage trial registry
A small indexed set (5 trials) with no open enrollment listed right now.
Corpus placement: #3,391 of 28,707 conditions by registered trial count.
5 US clinical trials · none currently recruiting · #3,391 of 28,707 conditions by registered trial count
Chronic Rhinosinusitis: 5 US clinical trials tracked, none currently recruiting.
Chronic Rhinosinusitis is the subject of 5 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. 3 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is AnaptysBio, running 1 of these trials.
Enrollment posture brief
Registry condition chronic-rhinosinusitis
OPEN 0 | RECR 0% | LATE 3 | EARLY 1 | RANK #3391 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)
Chronic Rhinosinusitis has no open enrollment in this registry pull (5 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Chronic Rhinosinusitis on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Chronic Rhinosinusitis is recruiting below its size-band peers.
0 of 5 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Chronic Rhinosinusitis research.
AnaptysBio accounts for 1 of 5 trials (20%). 5 distinct sponsors appear on at least one study for this condition label.
-
Typical Chronic Rhinosinusitis enrolment sits around 105 participants.
Median target enrolment is 105 among the 5 trials that report a genuine target (sentinel values excluded). 2 of those (40%) plan for fewer than 100 participants.
-
Chronic Rhinosinusitis research is mostly interventional.
5 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Indexed trials (enrollment closed)
5 total, page 1 of 1
Study Evaluating the Efficacy and Safety of Intranasal Administration of OPN-375 in Subjects With Chronic Rhinosinusitis With or Without the Presence of Nasal Polyps
Optinose US
NCT03781804
An Extension Study of Omalizumab in Participants With Chronic Rhinosinusitis With Nasal Polyps
Hoffmann-La Roche
NCT03478930
Etokimab in Adults With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
AnaptysBio
NCT03614923
Point-of-Care Computed Tomography (CT) Chronic Rhinosinusitis Study
Northwestern University
NCT00871286
Oral Versus Topical Antibiotics for Chronic Rhinosinusitis Exacerbations
University of Rochester
NCT01988779
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 1 |
| Phase 3 | 3 |
Top Sponsors
Named interventions
Most-linked intervention names on Chronic Rhinosinusitis records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Chronic Rhinosinusitis trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Chronic Rhinosinusitis page
5 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- No Chronic Rhinosinusitis trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- AnaptysBio sponsors the most Chronic Rhinosinusitis trials on record, review their full trial history before evaluating a specific study. See AnaptysBio's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Chronic Rhinosinusitis condition card totals 5 registered trials; most-linked intervention Mometasone Furoate Nasal Spray; top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.